DIM
3,3-Diindolylmethane
TL;DR
DIM is a cruciferous vegetable metabolite that shifts oestrogen metabolism toward 2-hydroxy metabolites. That biochemical effect is well demonstrated at 100-300 mg/day; whether it translates into clinical benefit for hormonal symptoms, acne or cancer risk is not established.
Ideal For
- People exploring oestrogen metabolism support with realistic expectations
- Adjunct interest alongside a cruciferous-rich diet
Avoid If
- Using hormonal contraception
- Pregnancy or breastfeeding
- Oestrogen-receptor-positive cancer, unless oncologist-directed
- Taking narrow therapeutic index drugs metabolised by CYP1A2
Frequently Asked Questions
Overview
DIM sits at an awkward point between a validated biomarker effect and an unproven clinical one. The biochemistry is not in dispute: DIM induces CYP1A1, shifting oestradiol metabolism toward 2-hydroxyoestrone and away from 16-alpha-hydroxyoestrone, and this ratio shift is reliably measurable in urine at supplemental doses. The interpretive leap comes next. The 2-hydroxy pathway has been characterised as the more favourable one on the basis of observational associations with breast cancer risk, but interventional evidence that changing the ratio changes outcomes is thin. Trials in cervical intraepithelial neoplasia have been mostly null, prostate work is early, and the popular uses — hormonal acne, oestrogen dominance, PMS, post-cycle support in bodybuilding — rest largely on mechanism and testimonial. DIM is also a genuine CYP inducer, which makes the interaction profile more serious than most supplements: hormonal contraceptives are the obvious concern. A harmless quirk worth knowing is that it turns urine orange.
How It Works
- Aryl hydrocarbon receptor ligand; induces CYP1A1
- Shifts oestrogen metabolism toward 2-hydroxy metabolites
- Weak aromatase inhibition and androgen receptor antagonism
- CYP induction underlies both the effect and the interaction risk
Quick Facts
- Shifts oestrogen metabolite ratio reliably; clinical benefit unproven
- Cervical dysplasia trials were largely null
- Can reduce hormonal contraceptive effectiveness
- Turns urine orange, which is harmless
Benefits & Outcomes
Estrogen Metabolism Support
DIM reliably shifts oestrogen metabolite ratios. Whether that shift improves any health outcome remains unestablished.
Estrogen Balance
Human trials confirm metabolite shifts; symptomatic outcome data is promising but limited.
Supporting Research5 studies
Effect of Diindolylmethane Supplementation on Low-Grade Cervical Cytological Abnormalities: Double-Blind, Randomised, Controlled Trial
Castanon A, Tristram A, Mesher D +6 more
No significant difference between DIM and placebo in cytology, colposcopic impression, HPV clearance or CIN2+ rates.
Developing phytoestrogens for breast cancer prevention
Phytoestrogens and related dietary compounds act as weak aromatase inhibitors with inconsistent clinical outcomes.
A Randomized, Placebo-Controlled Trial of Diindolylmethane for Breast Cancer Biomarker Modulation in Patients Taking Tamoxifen
Thomson CA, Chow HHS, Wertheim BC +5 more
DIM increased the urinary 2:16-alpha-hydroxyoestrone ratio and lowered endoxifen concentrations.
Oral Diindolylmethane (DIM): Pilot Evaluation of a Nonsurgical Treatment for Cervical Dysplasia
Del Priore G, Gudipudi DK, Montemarano N +3 more
Improvement rates did not differ significantly between DIM and placebo in CIN 2 or 3.
Pilot Study: Effect of 3,3'-Diindolylmethane Supplements on Urinary Hormone Metabolites in Postmenopausal Women with a History of Early-Stage Breast Cancer
Dalessandri KM, Firestone GL, Fitch MD +2 more
DIM significantly increased the 2-hydroxyoestrone to 16-alpha-hydroxyoestrone ratio versus placebo.
Safety Information
Potential Side Effects
Headache, nausea and gastrointestinal upset, more common above 300 mg/day. Harmless orange discolouration of urine. Rare reports of decreased sodium and, at high doses, hormonal symptom flares.
Contraindications
Not for use in pregnancy or breastfeeding. Anyone with hormone-sensitive cancer should only use it under oncology supervision, since altering oestrogen metabolism is not automatically beneficial.
Drug Interactions
- Hormonal contraceptives — CYP induction may reduce efficacy
- Tamoxifen and aromatase inhibitors — unpredictable interaction; avoid without oncology input
- CYP1A2 substrates such as clozapine and theophylline — altered levels
- Caffeine — metabolism may be accelerated
Pregnancy & Breastfeeding
Pregnancy: likely_unsafe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
100-300 mg
Best Time to Take
Once or twice daily with food
Best Form
Microencapsulated or bioavailability-enhanced DIM
Bioavailability
Crystalline DIM is very poorly absorbed; microencapsulated forms improve bioavailability several-fold.
Forms Compared
Microencapsulated DIM
Indole-3-carbinol
Cruciferous vegetables
Food & Timing
Take with a fat-containing meal; DIM is poorly water soluble.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.